Rifampin affects polymorphonuclear leukocyte interactions with bacterial and synthetic chemotaxins but not interactions with serum-derived chemotaxins.
Three independent experimental approaches support the hypothesis that rifampin competes for receptors on polymorphonuclear leukocytes (PMLs) with small peptide chemoattractants, e.g., N-formylmethionylleucylphenylalanine (FMLP), but not with serum-derived chemoattractants (C5a). First, rifampin inhi...
Сохранить в:
| Опубликовано в:: | Antimicrob Agents Chemother |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society for Microbiology (ASM)
1983
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC185941/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6318656/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.24.5.777 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|
